About Our Technology

Design Advantages

Features:

  • World's smallest implantable blood pump (25g)
  • World's first superficially implanted micro-pump, designed to be placed without cardiopulmonary bypass or sternotomy
  • World's smallest percutaneous lead
  • Designed to supplement native cardiac output
  • Designed to pump up to 3L/minute for partial circulatory support (PCS)
  • Implantation procedure designed for cardiovascular surgeons and, ultimately, interventional cardiologists
  • Designed for long-term support
  • Magnetically and hydrodynamically stabilized rotor design
  • Lightweight, rechargeable dual battery pack system (average power 14 hours)
  • Underlying intrinsic cardiac output provides fail-safe mechanism

Benefits:

  • Small size and minimally invasive implantation enables earlier, elective treatment for chronic heart failure patients (Class IIIb and early Class IV)
  • Increases total cardiac output and offloads the heart, allowing it to rest and potentially enabling beneficial recovery of heart function
  • Potential for physicians to treat a larger proportion of heart failure patients
  • Improvements in quality of life and hemodynamic function
  • Implantation is minimally invasive and involves an approximate 90 minute procedure, which can potentially lower risk and lead to rapid patient recovery
  • Small percutaneous lead facilitates exit site healing to minimize the risk of infection
  • Small size and lower volume flow rate (3L/min) is applicable to the development of a pediatric system
  • System may be modified to be fully-implantable with physiological feedback